Profile of brivaracetam and its potential in the treatment of epilepsy
Edoardo Ferlazzo,1,2 Emilio Russo,3 Laura Mumoli,1 Chiara Sueri,2 Sara Gasparini,1,2 Caterina Palleria,3 Angelo Labate,1 Antonio Gambardella,1 Giovambattista De Sarro,3 Umberto Aguglia1,2 1Department of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, 2Regional Epilepsy...
Saved in:
Main Authors: | Ferlazzo E, Russo E, Mumoli L, Sueri C, Gasparini S, Palleria C, Labate A, Gambardella A, De Sarro G, Aguglia U |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/7c8762e00d1b4a2985a2f631eeb0daef |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monotherapy for partial epilepsy: focus on levetiracetam
by: Antonio Gambardella, et al.
Published: (2008) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
by: Feyissa AM
Published: (2019) -
Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
by: L. Abraira, et al.
Published: (2021) -
Response: Sotos Syndrome and the added value of genetic workup in epilepsy surgery
by: Kenneth A. Myers
Published: (2021) -
Sotos syndrome and the added value of genetic workup in epilepsy surgery
by: Linda Bättig, et al.
Published: (2021)